Caspofungin
Need Assistance?
  • US & Canada:
    +
  • UK: +

Caspofungin

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Caspofungin acetate is the first in a new class of antifungals that inhibits the synthesis of beta (1, 3)-d-glucan, an essential component of the cell wall of filamentous fungi.

Category
Peptide APIs
Catalog number
BAT-010107
CAS number
162808-62-0
Molecular Formula
C52H88N10O15
Molecular Weight
1093.31
Caspofungin
Size Price Stock Quantity
50 mg $298 In stock
IUPAC Name
N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxypropyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide
Related CAS
179463-17-3 (acetate)
Appearance
White to Pale Yellow Solid
Density
1.4±0.1 g/cm3
Boiling Point
1408.1°C at 760 mmHg
Storage
Store at -20°C
InChI
InChI=1S/C52H88N10O15/c1-5-28(2)24-29(3)12-10-8-6-7-9-11-13-39(69)56-34-26-38(68)46(55-22-21-54)60-50(75)43-37(67)19-23-61(43)52(77)41(36(66)18-20-53)58-49(74)42(45(71)44(70)31-14-16-32(64)17-15-31)59-48(73)35-25-33(65)27-62(35)51(76)40(30(4)63)57-47(34)72/h14-17,28-30,33-38,40-46,55,63-68,70-71H,5-13,18-27,53-54H2,1-4H3,(H,56,69)(H,57,72)(H,58,74)(H,59,73)(H,60,75)/t28?,29?,30-,33-,34+,35+,36-,37+,38-,40+,41+,42+,43+,44+,45+,46+/m1/s1
InChI Key
JYIKNQVWKBUSNH-OGZDCFRISA-N
Canonical SMILES
CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O
1. Surface coatings with covalently attached caspofungin are effective in eliminating fungal pathogens
Bryan R. Coad,* Stephanie J. Lamont-Friedrich. J. Mater. Chem. B, 2015, 3, 8469—8476
Echinocandins were incubated with aldehyde-bearing surfaces and reductive amination was carried out using sodium cyanoborohydride. Then surfaces were washed using PBS solution alone, PBS followed by SDS solution, or PBS followed by SDS solution at 70 ℃. XPS revealed the relative amount of nitrogen remaining on the surface after washing (Fig. 3). The presence of nitrogen in the PBS-washed samples showed that all three echinocandins have the ability to adsorb to aldehyde plasma polymer surfaces. Using SDS washing, anidulafungin could be completely desorbed and small amounts of reversibly-adsorbed micafungin and caspofungin could be removed. These reductions are likely explained by the disruption of weak physical forces holding them to the surface. When washed with SDS at 70 ℃, physisorbed micafungin could be completely removed along with an additional loss of 0.4% N for caspofungin. The fact that only caspofungin (which amongst these echinocandins is capable of forming amine bonds with aldehyde-functionalized surfaces) remains after aggressive washing suggests that SDS washing at 70 ℃ is required to remove physisorbed compounds.
2. Review on fungal enzyme inhibitors–potential drug targets to manage human fungal infections
Jayapradha Ramakrishnan, Sudarshan Singh Rathore and Thiagarajan Raman*. RSC Adv.,2016, 6,42387–42401
Adaptive stress response is another potential echinocandin resistancemechanism. The highly dynamic nature of the fungal cell wall allows it to synthesize cell wall components even if any specific cell wall biosynthetic pathway is inhibited. Echinocandins induce a set of genes including HOG1, CEK1 and PKC MAP kinase cascade which is involved in the alteration of protein kinase C/Ca2+/calcineurin/Crz1, and high osmolarity glycerol, which results in compensatory increases in chitin synthesis. An increase in chitin synthesis protects against destabilizing environmental stresses created by echinocandin exposure. However, echinocandin resistance is uncommon unless other conditions like repeated therapy are undertaken among immunosuppressed patients. Moreover, echinocandins and chitin synthase inhibitors like calcineurin inhibitors, FK506 and cyclosporin A have been shown to demonstrate synergism, highlighting the potential for combination therapies with enhanced antifungal activity against A. fumigatus and C. neoformans. In addition, few in vitro studies have observed the supra MIC concentration of caspofungin in C. albicans strains. This is known as the paradoxical effect, wherein it synthesizes more chitin at low concentrations of caspofungin. The details of the therapeutic applications of antifungal agents are discussed in Table 2.
3. A sensitive liquid chromatography-tandem mass spectrometry method for monitoring the caspofungin trough plasma concentration and its association with caspofungin efficacy in intensive-care-unit patients
Qianting Yang, Taotao Wang, Yalin Dong. RSC Adv.,2015, 5,104806–104814
Invasive fungal infections (IFIs) have high morbidity and mortality, and are the fourth most common cause of nosocomial infections in intensive care unit (ICU) patients, accounting for about one in five of all infections in critically ill patients. ICU patients are susceptible to fungal infections because they often suffer from multiple diseases and organ dysfunction after receiving major surgery that involves postoperative catheter indwelling. Caspofungin was the first antifungal agent of the echinocandin family approved for the treatment of IFIs caused by Candida spp. and Aspergillus spp. in patients who are refractory to or intolerant of voriconazole.Caspofungin works by inhibiting the synthesis of β-(1,3)-D-glucan, which is an essential component of Candida and Aspergillus cell walls. The recommended dosage regimen of caspofungin is a loading dose of 70 mg followed by 50 mg daily that is administered intravenously over a 1 h period. Caspofungin is highly protein-bound (~96%) and metabolizes slowly in the liver. It is eliminated slowly from plasma, with a clearance rate of 10–12 mL min -1 and a half-life of 9–11 h.
4. Ocular penetration of caspofungin in a rabbit uveitis model
David Goldblum & Kathrin Fausch & Beatrice E. Frueh & Regula Theurillat & Wolfgang Thormann & Stefan Zimmerli. Graefe's Arch Clin Exp Ophthalmol (2007) 245:825-833
Single-dose kinetics of caspofungin acetate were studied over 24 h. Immediately before use, caspofungin acetate was dissolved in sterile 0.9% sodium chloride to a concentration of 0.5 mg/ml. Twenty-four hours after induction of uveitis, 16 rabbits were given 1 mg/kg caspofungin over 6 min by steady bolus injection via a central venous catheter. The drug dosage used corresponds to the standard dose recommended for the treatment of human fungal infections and is well tolerated by rabbits. Four animals per time point were sacrificed by cervical dislocation and subsequent exsanguination at 4, 8, 16, and 24 h after drug administration. Blood samples were collected during bleeding, and serum was separated by centrifugation. Aqueous humor was drawn from the freshly enucleated eyes with a tuberculin syringe using a 30-gauge needle. The cornea was excised at the limbus. After sectioning the eyes just behind the lens, vitreous humor was obtained by dissecting it carefully from the retina.
Online Inquiry
Verification code
Inquiry Basket